Interaction of pneumococcal phase variation, host and pressure/gas composition: Virulence expression of NanA, HylA, PspA and CbpA in simulated otitis media

Microbial Pathogenesis

Volumn 49, Issue 4, 2010, Pages 204-210

  Li Korotky, Ha Sheng ^a,b,c   Lo, Chia Yee ^a   Banks, Juliane M ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Human middle ear epithelial cell line; Otitis media; Phase variation; Simulated middle ear environment; Streptococcus pneumoniae; Virulence expression

Indexed keywords

CHOLINE BINDING PROTEIN A; HYALURONATE LYASE A; PNEUMOCOCCAL SURFACE PROTEIN A; SIALIDASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; AUDITORY TUBE; BACTERIAL VIRULENCE; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INCUBATION TIME; INOCULATION; MIDDLE EAR PRESSURE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; OTITIS MEDIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; TYMPANOSTOMY TUBE;

BACTERIAL PROTEINS; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; GASES; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; HYDROSTATIC PRESSURE; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; VIRULENCE FACTORS;

HYLA; STREPTOCOCCUS PNEUMONIAE;

EID: 77955257666     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2010.05.014     Document Type: Article

References (59)

1. Ah-Tye C., Paradise J.L., Colborn D.K. Otorrhea in young children after tympanostomy-tube placement for persistent middle-ear effusion: prevalence, incidence, and duration. Pediatrics 2001, 107:1251-1258.
2. Baril L., Dietemann J., Essevaz-Roulet M., Beniguel L., Coan P., Briles D.E., et al. Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults. Clin Exp Immunol 2006, 145:277-286.
3. Barocchi M.A., Censini S., Rappuoli R. Vaccines in the era of genomics: the pneumococcal challenge. Vaccine 2007, 25:2963-2973.
4. Beder L.B., Hotomi M., Ogami M., Yamauchi K., Shimada J., Billal D.S., et al. Clinical and microbiological impact of human bocavirus on children with acute otitis media. Eur J Pediatr 2009, 168:1365-1372.
5. Berry A.M., Lock R.A., Thomas S.M., Rajan D.P., Hansman D., Paton J.C. Cloning and nucleotide sequence of the Streptococcus pneumoniae hyaluronidase gene and purification of the enzyme from recombinant Escherichia coli. Infect Immun 1994, 62:1101-1108.
6. Bogaert D., Hermans P.W., Adrian P.V., Rumke H.C., de Groot R. Pneumococcal vaccines: an update on current strategies. Vaccine 2004, 22:2209-2220.
7. Bylander A. Upper respiratory tract infection and eustachian tube function in children. Acta Otolaryngol 1984, 97:343-349.
8. Chun Y.M., Moon S.K., Lee H.Y., Webster P., Brackmann D.E., Rhim J.S., et al. Immortalization of normal adult human middle ear epithelial cells using a retrovirus containing the E6/E7 genes of human papillomavirus type 16. Ann Otol Rhinol Laryngol 2002, 111:507-517.
9. Claverys J.P., Prudhomme M., Mortier-Barriere I., Martin B. Adaptation to the environment: Streptococcus pneumoniae, a paradigm for recombination-mediated genetic plasticity?. Mol Microbiol 2000, 35:251-259.
10. Crain M.J., Waltman W.D., Turner J.S., Yother J., Talkington D.F., McDaniel L.S., et al. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect Immun 1990, 58:3293-3299.
11. Dave S., Carmicle S., Hammerschmidt S., Pangburn M.K., McDaniel L.S. Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J Immunol 2004, 173:471-477.
12. Diven W.F., Glew R.H., LaMarco K.L. Hydrolase activity in acute otitis media with effusion. Ann Otol Rhinol Laryngol 1985, 94:415-418.
13. Dowson C.G., Barcus V., King S., Pickerill P., Whatmore A., Yeo M. Horizontal gene transfer and the evolution of resistance and virulence determinants in Streptococcus. Soc Appl Bacteriol Symp Ser 1997, 26:42S-51S.
14. Ferreira D.M., Darrieux M., Silva D.A., Leite L.C.C., Ferreira J.M.C., Ho P.L., et al. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin Vaccine Immunol 2009, 16:636-645.
15. Giebink G.S. Otitis media: the chinchilla model. Microb Drug Resist Mech Epidemiol Dis 1999, 5:57-72.
16. Hakenbeck R., Balmelle N., Weber B., Gardes C., Keck W., de Saizieu A. Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae. Infect Immun 2001, 69:2477-2486.
17. Hava D.L., LeMieux J., Camilli A. From nose to lung: the regulation behind Streptococcus pneumoniae virulence factors. Mol Microbiol 2003, 50:1103-1110.
18. Jedrzejas M.J. Unveiling molecular mechanisms of pneumococcal surface protein A interactions with antibodies and lactoferrin. Clin Chim Acta 2006, 367:1-10.
19. Jedrzejas M.J., Mello L.V., de Groot B.L., Li S. Mechanism of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. Structures of complexes with the substrate. J Bio Chem 2002, 277:28287-28297.
20. Kadioglu A., Weiser J.N., Paton J.C., Andrew P.W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008, 6:288-301.
21. Kim J.O., Romero-Steiner S., Sorensen U.B., Blom J., Carvalho M., Barnard S., et al. Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae. Infect Immun 1999, 67:2327-2333.
22. Kim J.O., Weiser J.N. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis 1998, 177:368-377.
23. LaMarco K.L., Diven W.F., Glew R.H. Experimental alteration of chinchilla middle ear mucosae by bacterial neuraminidase. Ann Otol Rhinol Laryngol 1986, 95:304-308.
24. LaMarco K.L., Diven W.F., Glew R.H., Doyle W.J., Cantekin E.I. Neuraminidase activity in middle ear effusions. Ann Otol Rhinol Laryngol 1984, 93:76-84.
25. Lee L.T., Howe C. Pneumococcal neuraminidase. J Bacteriol 1966, 91:1418-1426.
26. Li-Korotky H.S., Banks J.M., Lo C.Y., Zeng F.R., Stolz D.B., Swarts J.D., et al. Interaction of pneumococcal phase variation and middle ear pressure/gas composition: an in vitro model of simulated otitis media. Microb Pathog 2008, 45:201-206.
27. Li-Korotky H.S., Lo C.Y., Zeng F.R., Lo D., Banks J.M. Interaction of phase variation, host and pressure/gas composition: pneumococcal gene expression of PsaA, SpxB, Ply and LytA in simulated middle ear environments. Int J Pediatr Otorynolaryngol 2009, 73:1417-1422.
28. Li H.S., Doyle W.J., Swarts J.D., Hebda P.A. Suppression of epithelial ion transport transcripts during pneumococcal acute otitis media in the rat. Acta Oto-Laryngol 2002, 122:488-494.
29. Lu L., Lamm M.E., Li H., Corthesy B., Zhang J.R. The human polymeric immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4. J Biol Chem 2003, 278:48178-48187.
30. Mandel E.M., Casselbrant M.L., Kurs-Lasky M. Acute otorrhea: bacteriology of a common complication of tympanostomy tubes. Ann Otol Rhinol Laryngol 1994, 103:713-718.
31. Moscoso M., Garcia E., Lopez R. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol 2006, 188:7785-7795.
32. Murdoch C., Read R.C., Zhang Q., Finn A. Choline-binding protein A of Streptococcus pneumoniae elicits chemokine production and expression of intercellular adhesion molecule 1 (CD54) by human alveolar epithelial cells. J Infect Dis 2002, 186:1253-1260.
33. O'Toole R.D., Goode L., Howe C. Neuraminidase activity in bacterial meningitis. J Clin Invest 1971, 50:979-985.
34. Ogunniyi A.D., LeMessurier K.S., Graham R.M., Watt J.M., Briles D.E., Stroeher U.H., et al. Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Infect Immun 2007, 75:1843-1851.
35. Orihuela C.J., Gao G., Francis K.P., Yu J., Tuomanen E.I. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 2004, 190:1661-1669.
36. Paton J.C., Andrew P.W., Boulnois G.J., Mitchell T.J. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Ann Rev Microbiol 1993, 47:89-115.
37. Pereira M.B., Pereira D.R., Costa S.S. Tympanostomy tube sequelae in children with otitis media with effusion: a three-year follow-up study. Rev Bras Otorrinolaringol (Engl Ed) 2005, 71:415-420.
38. Pettigrew M.M., Fennie K.P., York M.P., Daniels J., Ghaffar F. Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types. Infect Immun 2006, 74:3360-3365.
39. Pichichero M.E., Casey J.R. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era. Pediatr Infect Dis J 2007, 26:S12-S16.
40. Pichichero M.E., Casey J.R., Hoberman A., Schwartz R. Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006. Clin Pediatr 2008, 47:901-906.
41. Pimenta F.C., Miyaji E.N., Areas A.P., Oliveira M.L., de Andrade A.L., Ho P.L., et al. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice. Infect Immun 2006, 74:4939-4944.
42. Ponnuraj K., Jedrzejas M.J. Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution. J Mol Biol 2000, 299:885-895.
43. Quin L.R., Moore Q.C., McDaniel L.S. Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice. Infect Immun 2007, 75:2067-2070.
44. Revai K, Patel JA, Grady JJ, Chonmaitree T. Tympanometric findings in young children during upper respiratory tract infections with and without acute otitis media. Pediatr Infect Dis J 2008, 27: 292-295.
45. Rosenow C., Ryan P., Weiser J.N., Johnson S., Fontan P., Ortqvist A., et al. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol 1997, 25:819-829.
46. Rovers M.M., Krabbe P.F., Straatman H., Ingels K., van der Wilt G.J., Zielhuis G.A. Randomised controlled trial of the effect of ventilation tubes (grommets) on quality of life at age 1-2 years. Arch Dis Child 2001, 84:45-49.
47. Schmittgen T.D., Zakrajsek B.A., Mills A.G., Gorn V., Singer M.J., Reed M.W. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 2000, 285:194-204.
48. Senkovich O., Cook W.J., Mirza S., Hollingshead S.K., Protasevich I.I., Briles D.E., et al. Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism. J Mol Biol 2007, 370:701-713.
49. Serrano I., Melo-Cristino J., Ramirez M. Heterogeneity of pneumococcal phase variants in invasive human infections. BMC Microbiol 2006, 6:1-6.
50. Shaper M., Hollingshead S.K., Benjamin W.H., Briles D.E. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin. Infect Immun 2004, 72(9):5031-5040.
51. Smith B.L., Hostetter M.K. C3 as substrate for adhesion of Streptococcus pneumoniae. J Infect Dis 2000, 182:497-508.
52. Tong H.H., Blue L.E., James M.A., DeMaria T.F. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun 2000, 68:921-924.
53. Tong H.H., Grants I., Liu X., DeMaria T.F. Comparison of alteration of cell surface carbohydrates of the chinchilla tubotympanum and colonial opacity phenotype of Streptococcus pneumoniae during experimental pneumococcal otitis media with or without an antecedent influenza A virus infection. Infect Immun 2002, 70:4292-4301.
54. Tong H.H., Liu X., Chen Y., James M., Demaria T. Effect of neuraminidase on receptor-mediated adherence of Streptococcus pneumoniae to chinchilla tracheal epithelium. Acta Otolaryngol 2002, 122:413-419.
55. Vaile L., Williamson T., Waddell A., Taylor G. Interventions for ear discharge associated with grommets (ventilation tubes). Cochrane Database Syst Rev 2006, (2).
56. Weiser J.N. Phase variation in colony opacity by Streptococcus pneumoniae. Microb Drug Resist 1998, 4:129-135.
57. Weiser J.N., Austrian R., Sreenivasan P.K., Masure H.R. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 1994, 62:2582-2589.
58. Winther B., Hayden F.G., Arruda E., Dutkowski R., Ward P., Hendley J.O. Viral respiratory infection in schoolchildren: effects on middle ear pressure. Pediatrics 2002, 109:826-832.
59. Yamanaka N., Hotomi M., Billal D.S. Clinical bacteriology and immunology in acute otitis media in children. J Infect Chemother 2008, 14:180-187.